Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Contipro is a leading global manufacturer of high-quality hyaluronic acid and a pioneer in connective tissue research. Based in the Czech Republic, the company specializes in the production of pharmaceutical-grade sodium hyaluronate and the development of innovative medical devices and drug delivery systems. Their core expertise lies in the chemical modification of hyaluronan to create advanced biomaterials, including nanofibers and hydrogels. Contipro's portfolio includes established wound healing products such as Hyiodine and Sorelex, alongside a robust R&D pipeline focused on targeted drug delivery and tissue engineering. The company operates integrated R&D and manufacturing facilities, serving the pharmaceutical, cosmetic, and medical device industries worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Contipro.